Clinical Trial Update: Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh. [Phase 4]

View source ↗

Summary

Phase 4 effectiveness trial assessing protection from the hepatitis E vaccine in pregnant women in Bangladesh; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis E

Drugs mentioned

• HEV-239 vaccine (Hecolin) (hepatitis E vaccine (HEV-239))

Snippet

Sponsor: Norwegian Institute of Public Health | Conditions: Hepatitis E Infection | Phase 4 | Status: COMPLETED